US Patent Office Re-Affirms VISICU's eICU® Patent with Re-Examination

Business Wire, Sept 27, 2006

Life Saving Technology Recognized for Innovation

BALTIMORE -- VISICU, Inc. (NASDAQ:EICU) has been granted a reexamination certificate for patent No. 6,804,656 from the United States Patent and Trademark Office for its "SYSTEM AND METHOD FOR PROVIDING CONTINUOUS, EXPERT NETWORK CRITICAL CARE SERVICES FROM A REMOTE LOCATION(S)" - eICU([R]) Program.

A reexamination of the claims of the patent was requested in January 2005 by a third party desiring to implement their own solution and citing references that required further consideration by the Patent Office. During the re-examination process, minor amendments to the claims were made that were consistent with the eICU Program that is in place at over 30 health systems, representing approximately 5,000 beds. The eICU Program features a centrally located, remote monitoring system equipped with high fidelity telemedicine and proprietary early warning and intervention software. VISICU is the first company to receive such U.S. patent protection and the first to bring remote critical care (eICU centers) to the marketplace.

The eICU Program, offered only through VISICU, enables hospitals to meet stringent patient care safety standards and assures fundamental changes in hospital critical care. The eICU Program connects the patient to the doctor 24/7 and allows hospitals to leverage their intensivist resources to care for large numbers of critically-ill patients simultaneously. This new care delivery model enables optimal use of scarce healthcare resources while simultaneously improving patient outcomes and financial results for health systems.

"VISICU is pleased that the Patent Office, through the issuance of the reexamination certificate, continues to recognize the innovation of the eICU Program - a Program that continues to be central to saving lives and managing important critical care resources in health systems throughout the United States," said Frank Sample, CEO of VISICU. "This action by the US Patent Office will re-assure customers and prospects that this remote clinical solution is protected by this patent."

About VISICU

VISICU, Inc. (NASDAQ:EICU) is a healthcare information technology and clinical solutions company focused on transforming the delivery of critical care through its eICU([R]) Program. The eICU Program restructures the practice of critical care by using remote monitoring technology to allow health systems to centralize scarce critical care trained staff to improve coverage and for earlier intervention to prevent or manage crises. A study (Crit Care Med 2004; 32:31-38) documented the clinical and financial benefits of the program. The eICU Program enables hospitals to meet The Leapfrog Group's ICU patient care safety standards. For more information, visit www.VISICU.com. VISICU([R]) and eICU([R])are registered trademarks of VISICU, Inc. All rights reserved. All other brand names, product names, company names, trademarks and service marks are the property of their respective owners.

Safe Harbor Statement

This release contains forward-looking statements that are made pursuant to the provisions of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve a number of risks and uncertainties. Investors are cautioned that statements in this release that are not strictly historical statements constitute forward-looking statements. It is important to note that the company's performance, and actual results, financial condition or business could differ materially from those expressed in the forward-looking statements. The words "may", "could", "would", "should", "outlook", "positions us", "guidance", "expects", "estimates", "intends", "plans", "projects", "anticipates", "believes", "predicts", "potential" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could materially affect actual results, levels of activity, performance or achievements. Factors that could cause results to differ materially from current expectations include, but are not limited to: market acceptance of our principal product offering and any new product releases; the price, performance and reliability of our products and services; our ability to attract and retain new customers and renewal rates of our existing customers; unanticipated delays or problems in releasing new products and services; financial and budget constraints of hospitals, changes in our pricing practices or our competitors' pricing practices and changes in the healthcare industry; the introduction or availability of competing products or services and other competitive factors; and changes in the government regulation of our products and services.